Although these will be no match for modern products ... Pharmaceuticals (who developed emtricitabine) by Gilead, enabling Gilead to formulate Truvada, which became the first blockbuster drug in ...

Indian pharmaceutical ... of HIV is underway. Gilead's collaboration with pharmaceutical firms across the globe, also ...

Adding to India’s already significant contribution in supplying HIV medicines to ... s Laboratories’, ‘Emcure Pharmaceuticals’, ‘Hetero Labs’ and ‘Mylan’ that is a unit of the ...

Gilead started life as a start-up focused on antivirals and, less than 40 years later, is firmly established as a top 20 pharmaceutical ... Gilead reported HIV product sales at $4.7 billion ...

BMO Capital Markets analyst Evan Seigerman in a note to investors called Gilead’s third-quarter performance “consistent” and ...

Pfizer and Mylan will continue to operate independent entities in Japan, but will collaborate on current and future generic products, sharing the costs and profits. The Japanese pharmaceutical ...

Bresch’s company, Mylan, recently raised prices on the EpiPen and several other treatments they sell. An EpiPen dose might cost as much as $600, which is . . . about half of what the typical ...

The conference is sponsored by the pharmaceutical firms, Gilead, Mylan and Roche of Switzerland, On Monday Simon Sedaula Mwangi was to present; “Consumer Demand Driven for HIV Prevention Pills ...

Mylan's stock price has jumped more than 70% since Bresch stepped in as CEO at the generic-drug maker in 2012. She continues to break new ground at the company, with $6.8 billion in revenue; a $1. ...

We don't understand it well, but it doesn't happen as much as it used to, thanks to antiretroviral therapy (ART), the drugs that treat HIV. Still, it's a significant threat in AIDS patients.

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

Medication patches are available in a limited number of dosage strengths. Occasionally, some patients require a different dosage of a medication than the dosages commercially available in patch ...